Medical/Pharmaceuticals News & Press Release Distribution

Medical/Pharmaceuticals

APAC
Global

I-Mab and ABL Bio Announce Latest Updates of PD-L1 and 4-1BB Bispecific Antibody TJ-L14B/ABL503

- Among 14 efficacy-evaluable patients in the ongoing Phase 1 study, one achieved a complete response, one had partial response and two unconfirmed partial responses; maximum tolerated dose not yet reached - Patent rights secured for TJ-L14B/ABL503 in Eurasia until 2039 ROCKVILLE, ...

2023-10-10 20:00 1494

Novel classification of allergic disorders published by the European Academy of Allergy and Clinical Immunology: SIAF

Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper published in 'Allergy' DAVOS, Switzerland, Oct. 10, 2023 /PRNewswire/ -- The revision of the current allergic disease nomenclature based on symptoms and organ dysfunction has been l...

2023-10-10 19:10 1427

GenFleet Starts Phase Ib/II Trial of GFH009 (Highly Selective CDK9 Inhibitor) Treating Patients with Relapsed/Refractory Peripheral T-cell Lymphomas (PTCL)

SHANGHAI, Oct. 10, 2023 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced the first subject was dosed in a phase Ib/II trial of GFH009 (a highly selective CDK9 inhibitor) treating relapsed/r...

2023-10-10 19:00 1503

Scorpion Therapeutics and Pierre Fabre Laboratories Announce First Patient Dosed in Phase 1/2 Clinical Trial of STX-721, a Mutant-Selective EGFR Exon 20 Inhibitor for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer

-- STX-721 is characterized by high selectivity and a potentially best-in-class profile -- -- Scorpion's second program to enter clinical development this year -- -- One of two EGFR programs being developed with Pierre Fabre Laboratories -- BOSTON and CASTRES, France, Oct. 10, 2023 /PRNewswire/...

2023-10-10 18:00 1591

Frost & Sullivan Launches the EmpowerHer Program to Bridge the Growth Gap in Women's Health

Global Think Tanks and Collaboration to Drive Innovation and Empowerment in Women's Health SAN ANTONIO, Oct. 10, 2023 /PRNewswire/ -- Frost & Sullivan, a renowned leader in fostering innovation and driving transformative change, proudly announces the launch of its groundbreaking"EmpowerHer" Grow...

2023-10-10 15:12 1334

Frost & Sullivan Launches the EmpowerHer Program to Bridge the Growth Gap in Women's Health

Recbio signed a strategic cooperation agreement with Zimbabwe National Biotechnology Administration and ICGEB China Regional Research Centre

TAIZHOU, China, Oct. 10, 2023 /PRNewswire/ -- On October 8, 2023, Dr. Deckster Tonny SAVADYE, CEO of Zimbabwe NBA, and Dr.Yang Yili, International Centre for Genetic Engineering and Biotechnology China Regional Research Centre(ICGEB), visited Recbio. Dr. SAVADYE and his team conducted an on-the-s...

2023-10-10 13:54 4618

Recbio signed a strategic cooperation agreement with Zimbabwe National Biotechnology Administration and ICGEB China Regional Research Centre

Fullerton Health and Connections MindHealth Recommend a Framework for Action to Enhance Mental Health at the Workplace

SINGAPORE, Oct. 10, 2023 /PRNewswire/ -- Fullerton Health & Connections MindHealth are pleased to announce the release of a Healthcare Brief that addresses critical challenges surrounding mental health in the workplace. Titled "A Framework for Action: Enhancing Mental Health in the Workplace", th...

2023-10-10 13:39 3938

Fullerton Health and Connections MindHealth Recommend a Framework for Action to Enhance Mental Health at the Workplace

CanariaBio and Hikma announce the signing of distribution and license agreement for oregovomab in MENA Region

SEOUL, South Korea, Oct. 10, 2023 /PRNewswire/ -- CanariaBio Inc. and Hikma MENA FZE, part of Hikma Pharmaceuticals PLC (Hikma), today announced the signing of distribution and license agreement for oregovomab in theMiddle East andNorth Africa (MENA) region. "We are thrilled to partner with Hi...

2023-10-10 12:00 1654

AffaMed Technologies Announces Licensing of EVOLUX®- a novel extended monofocal intraocular lens (IOL) designed to provide better intermediate vision and equivalent distance vision when compared to a standard monofocal IOL

Expands Portfolio of Cataract Surgery Solutions for Patients in Greater China to New Extended Monofocal Segment AffaMed Therapeutics and SIFI Leadership Celebrate Strong Progress of the AffaMed Technologies Joint-Venture BEIJING, Oct. 10, 2023 /PRNewswire/ -- AffaMed Technologies ("AffaMed"), a ...

2023-10-10 09:00 2652

Kaneka Files Patent Infringement Lawsuit Against CoCrystal

TOKYO, Oct. 10, 2023 /PRNewswire/ -- On October 5, 2023, Kaneka Corporation filed a lawsuit inthe United States District Court for the Eastern District of New York against Cocrystal Technology Co. Ltd. and Cocrystal Health Industry Co. Ltd. (collectively "CoCrystal") seeking an injunction and mon...

2023-10-10 03:47 2537

Dr. Ming H. Wu, Former Senior Vice President of Engineering at Edwards Lifesciences, Joins Medeologix as Board Member and Advisor

NEW TAIPEI CITY, Taiwan, Oct. 9, 2023 /PRNewswire/ -- Medeologix, a global medical device contract development and manufacturing company known for its one-stop shop service with engineering excellence, is pleased to announce that Dr.Ming H. Wu has joined as a board member and advisor.

2023-10-09 23:00 1704

Dr. Ming H. Wu, Former Senior Vice President of Engineering at Edwards Lifesciences, Joins Medeologix as Board Member and Advisor

Omega Healthcare Launches Technology-Enabled Solutions to Improve Revenue Cycle Outcomes as Healthcare Organizations Face Mounting Financial Pressures

The Omega Digital Platform (ODP) leverages advanced proprietary technologies to streamline workflows and improve financial performance BOCA RATON, Fla., Oct. 9, 2023 /PRNewswire/ -- Omega Healthcare announced today the launch of its Omega Digital Platform (ODP), designed to help healthcare organ...

2023-10-09 21:00 1863

TransThera announces two oral presentations of tinengotinib clinical data at 2023 ESMO and SABCS annual meetings

NANJING, China, Oct. 9, 2023 /PRNewswire/ -- TransThera Sciences (Nanjing) Inc., a clinical-stage biopharmaceutical company focused on inventing differentiated drugs for global patients, today announces to deliver two oral presentations of tinengotinib clinical data in cholangiocarcinoma (CCA) at...

2023-10-09 21:00 1602

bioSeedin Biopharma Developer Innovation Conference Held to Accelerate Global Pharmaceutical Innovation and Collaboration

BOSTON, Oct. 9, 2023 /PRNewswire/ -- Recently, the fifth Biopharma Developer Innovation Conference (BDIC) & 2023 bioSeedin Annual Meeting was successfully held inShanghai, China. This conference was hosted by bioSeedin and co-organized by ACROBiosystems (SZ.301080) to promote technical exchanges ...

2023-10-09 20:00 1606

Kexing Biopharm Holds China-MENA & South Asia Pharmaceutical Cooperation High-end Forum, Aiming at Foreign Emerging Markets

SHENZHEN, China, Oct. 9, 2023 /PRNewswire/ -- The 2023 China-MENA & South Asia Pharmaceutical Cooperation High-end Forum and Kexing Biopharm's Series of Globalization Activities were successfully held recently. MENA and South Asia are recognized as pivotal regions for Kexing Biopharm's overseas ...

2023-10-09 19:09 1789

Gallup Partners with Radiant Foundation on New Global Report on Spirituality as a Tool to Support Mental Health

Gallup-led meta-analysis establishes a new framework for understanding the strong link between spirituality and religion and better global wellbeing from 10 years of World Poll data LONDON, Oct. 9, 2023 /PRNewswire/ -- On the eve World Mental Health Day, Radiant Foundation's Faith & Media Initia...

2023-10-09 19:00 2138

AACR OVARIAN CANCER CONFERENCE PRESENTATION

HIGHLIGHTS * Data from preclinical studies in ovarian cancer presented at premier international conference inBoston, USA. * Results indicate that Amplia's proprietary FAK inhibitor narmafotinib (AMP945) performs better than standard-of-care in models of chemotherapy-resistant high-grade ser...

2023-10-09 15:18 1396

Over 1,100 exhibitors commit to attend 2024 China Association of Clinical Laboratory Practice Expo (CACLP) and China IVD Supply Chain Expo (CISCE)

* The 21st edition of CACLP and the 4th edition of CISCE will take place from 16 - 18 March at Chongqing International Expo Center, China. * Concurrent with the tradeshows, the 9th China Experimental Medicine Conference and Series Sessions, the 11th China IVD Industry Development Conference a...

2023-10-09 15:16 1955

Over 1,100 exhibitors commit to attend 2024 China Association of Clinical Laboratory Practice Expo (CACLP) and China IVD Supply Chain Expo (CISCE)

Innovent Announces First Patient Dosed in the Phase 3 Clinical Study (STAR) of Efdamrofusp Alfa (IBI302), a First-in-class Ophthalmic Anti-VEGF and Anti-Complement Bispecific Fusion Protein for the Treatment of Neovascular Age-related Macular Degeneration

ROCKVILLE, Md. and SUZHOU, China, Oct. 9, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and...

2023-10-09 08:00 5994

CANbridge Announces Marketing Approval of CAN108 (/LIVMARLI®) in Taiwan for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome (ALGS)

* LIVMARLI is the First and Only Treatment Approved in Taiwan for Cholestatic Pruritus in ALGS * LIVMARLI is approved for Cholestatic Pruritus in ALGS in the US, Canada, Europe, Mainland China, and other regions globally BEIJING and BURLINGTON, Mass. ,Oct. 8, 2023 /PRNewswire/ -- CANbridge Pha...

2023-10-09 08:00 1625

1 ... 151 152 153154155 156 157 ... 617